Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review

MLA

Ilaria De Benedetto, et al. “Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review.” Future Pharmacology, vol. 4, no. 1, Jan. 2024, pp. 103–14. EBSCOhost, https://doi.org/10.3390/futurepharmacol4010008.

APA

Ilaria De Benedetto, Silvia Corcione, Carlotta Giambra, Matteo Ferrante, Simone Mornese Pinna, Elisa Zanotto, Alice Palermiti, Francesca Sidoti, Luca Scaglione, Cecilia Grosso, Martina Billi, Tommaso Lupia, Sara Soloperto, Jessica Cusato, Cristina Costa, Antonio D’Avolio, & Francesco Giuseppe De Rosa. (2024). Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review. Future Pharmacology, 4(1), 103–114. https://doi.org/10.3390/futurepharmacol4010008

Chicago

Ilaria De Benedetto, Silvia Corcione, Carlotta Giambra, Matteo Ferrante, Simone Mornese Pinna, Elisa Zanotto, Alice Palermiti, et al. 2024. “Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review.” Future Pharmacology 4 (1): 103–14. doi:10.3390/futurepharmacol4010008.